Advertisement

Sentinel Node Biopsy in Oral Cancer

  • Krishnakumar Thankappan
  • Moni Abraham KuriakoseEmail author
Chapter

Abstract

The status of the cervical nodes is an important prognosticator in patients with oral cavity squamous cell carcinoma (OSCC) [1]. There is a high incidence of occult metastasis, even in patients with no clinical or radiological evidence of lymph nodal metastasis (N0). This ranges from 10 to 50 % depending on the primary tumor characteristics [2–4]. Despite this, we currently have no accepted noninvasive diagnostic modality for identification of occult regional disease [1].

Keywords

Sentinel Lymph Node Sentinel Lymph Node Biopsy Neck Dissection Isolate Tumor Cell Occult Metastasis 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. 1.
    de Bree R, Takes RP, Castelijns JA, Medina JE, Stoeckli SJ, Mancuso AA, Hunt JL, Rodrigo JP, Triantafyllou A, Teymoortash A, Civantos FJ, Rinaldo A, Pitman KT, Hamoir M, Robbins KT, Silver CE, Hoekstra OS, Ferlito A. Advances in diagnostic modalities to detect occult lymph node metastases in head and neck squamous cell carcinoma. Head Neck. 2014. doi: 10.1002/hed.23814.PubMedCentralGoogle Scholar
  2. 2.
    van den Brekel MW, van der Waal I, Meijer CJ, et al. The incidence of micrometastases in neck dissection specimens obtained from elective neck dissections. Laryngoscope. 1996;106:987–91.CrossRefPubMedGoogle Scholar
  3. 3.
    Teichgraeber JF, Clairmont AA. The incidence of occult metastases for cancer of the oral tongue and floor of the mouth: treatment rationale. Head Neck. 1984;7:15–21.CrossRefGoogle Scholar
  4. 4.
    Hosal AS, Carrau RL, Johnson JT, Myers EN. Selective neck dissection in the management of the clinically node-negative neck. Laryngoscope. 2000;110:2037–40.CrossRefPubMedGoogle Scholar
  5. 5.
    D’Cruz AK, Dandekar MR. Elective versus therapeutic neck dissection in the clinically node negative neck in early oral cavity cancers: do we have the answer yet? Oral Oncol. 2011;47(9):7802. doi: 10.1016/j.oraloncology.2011.06.013.Google Scholar
  6. 6.
    D’Cruz AK, Siddachari RC, Walvekar RR, Pantvaidya GH, Chaukar DA, Deshpande MS, Pai PS, Chaturvedi P. Elective neck dissection for the management of the N0 neck in early cancer of the oral tongue: need for a randomized controlled trial. Head Neck. 2009;31(5):618–24.CrossRefPubMedGoogle Scholar
  7. 7.
    Woolgar JA, Beirne JC, Vaughn ED, et al. Correlation of histopathologic findings with clinical and radiologic assessments of cervical lymph-node metastases in oral cancer. Int J Oral Maxillofac Surg. 1995;24:30–7.CrossRefPubMedGoogle Scholar
  8. 8.
    Morton DL, Thompson JF, Cochran AJ, Mozzillo N, Nieweg OE, Roses DF, Hoekstra HJ, Karakousis CP, Puleo CA, Coventry BJ, Kashani-Sabet M, Smithers BM, Paul E, Kraybill WG, McKinnon JG, Wang HJ, Elashoff R, Faries MB, MSLT Group. Final trial report of sentinel-node biopsy versus nodal observation in melanoma. N Engl J Med. 2014;370(7):599–609. doi: 10.1056/NEJMoa1310460.CrossRefPubMedPubMedCentralGoogle Scholar
  9. 9.
    Wetzig N, Gill PG, Zannino D, Stockler MR, Gebski V, Ung O, Campbell I, Simes RJ. Sentinel lymph node based management or routine axillary clearance? Three-year outcomes of the RACS sentinel node biopsy versus axillary clearance (SNAC) 1 trial. Ann Surg Oncol. 2014;15.Google Scholar
  10. 10.
    Stacker SA, Achen MG, Jussila L, et al. Lymphangiogenesis and cancer metastasis. Nat Rev Cancer. 2002;2:573–83.CrossRefPubMedGoogle Scholar
  11. 11.
    Luk SC, Nopajaroonsri C, Simon GT. The architecture of the normal lymph node and hemolymph node. A scanning and transmission electron microscopic study. Lab Invest. 1973;29:258–65.PubMedGoogle Scholar
  12. 12.
    Shah JP, Candela FC, Poddar AK. The patterns of cervical lymph node metastases from squamous carcinoma of the oral cavity. Cancer. 1990;66:109–13.CrossRefPubMedGoogle Scholar
  13. 13.
    Lindberg R. Distribution of cervical lymph node metastases from squamous cell carcinoma of the upper respiratory and digestive tracts. Cancer. 1972;29:1446–50.CrossRefPubMedGoogle Scholar
  14. 14.
    Atula T, Hunter KD, Cooper LA, Shoaib T, Ross GL, Soutar DS. Micrometastases and isolated tumour cells in sentinel lymph nodes in oral and oropharyngeal squamous cell carcinoma. Eur J Surg Oncol. 2009;35(5):532–8. doi: 10.1016/j.ejso.2008.12.014.CrossRefPubMedGoogle Scholar
  15. 15.
    Seaman WB, Powers WE. Studies on the distribution of radioactive colloidal gold in regional lymph nodes containing cancer. Cancer. 1955;8:1044–6.CrossRefPubMedGoogle Scholar
  16. 16.
    Gould EA, Winship T, Philbin PH, et al. Observations on a ‘sentinel node’ in cancer of the parotid. Cancer. 1960;13:77–8.CrossRefPubMedGoogle Scholar
  17. 17.
    Cabanas RM. An approach for the treatment of penile carcinoma. Cancer. 1977;39:456–66.CrossRefPubMedGoogle Scholar
  18. 18.
    Wespes E, Simon J, Schulman CC. Cabanas approach: is sentinel node biopsy reliable for staging penile carcinoma? Urology. 1986;28:278–9.CrossRefPubMedGoogle Scholar
  19. 19.
    Morton DL, Wen DR, Wong JH, et al. Technical details of intraoperative lymphatic mapping for early stage melanoma. Arch Surg. 1992;127:392–9.CrossRefPubMedGoogle Scholar
  20. 20.
    Alex JC, Krag DN. The gamma-probe-guided resection of radiolabeled primary lymph nodes. Surg Oncol Clin N Am. 1996;5:33–41.PubMedGoogle Scholar
  21. 21.
    Morton DL, Thompson JF, Essner R, et al., Multicenter Selective Lymphadenectomy Trial Group. Validation of the accuracy of intraoperative lymphatic mapping and sentinel lymphadenectomy for early-stage melanoma: a multicenter trial. Ann Surg. 1999;230:453–63. [discussion 463–65].Google Scholar
  22. 22.
    Thompson JF, McCarthy WH, Bosch CM, et al. Sentinel lymph node status as an indicator of the presence of metastatic melanoma in regional lymph nodes. Melanoma Res. 1995;5:255–60.CrossRefPubMedGoogle Scholar
  23. 23.
    Pijpers R, Collet GJ, Meijer S, et al. The impact of dynamic lymphoscintigraphy and gamma probe guidance on sentinel node biopsy in melanoma. Eur J Nucl Med. 1995;22:1238–41.CrossRefPubMedGoogle Scholar
  24. 24.
    Giuliano AE, Dale PS, Turner RR, et al. Improved axillary staging of breast cancer with sentinal lymphadenectomy. Ann Surg. 1995;222:394–401.CrossRefPubMedPubMedCentralGoogle Scholar
  25. 25.
    Monroe MM, Lai SY. Sentinel lymph node biopsy for oral cancer: supporting evidence and recent novel developments. Curr Oncol Rep. 2014;16(5):385. doi: 10.1007/s11912-014-0385-1.CrossRefPubMedGoogle Scholar
  26. 26.
    Ross GL, Soutar DS, MacDonald DG, et al. Sentinel node biopsy in head and neck cancer: preliminary results of a multicenter trial. Ann Surg Oncol. 2004;11:690–6.CrossRefPubMedGoogle Scholar
  27. 27.
    Ross GL, Shoaib T, Soutar DS, et al. The First International Conference on Sentinel node biopsy in mucosal head and neck cancer and adoption of a multicenter trial protocol. Ann Surg Oncol. 2002;9:406–10.CrossRefPubMedGoogle Scholar
  28. 28.
    Gallegos-Hernandez JF, Hernandez-Hernandez DM, Flores-Diaz R, et al. The number of sentinel nodes identified as prognostic factor in oral epidermoid cancer. Oral Oncol. 2005;41:947–52.CrossRefPubMedGoogle Scholar
  29. 29.
    McMasters KM, Reintgen DS, Ross MI, et al. Sentinel lymph node biopsy for melanoma: how many radioactive nodes should be removed? Ann Surg Oncol. 2001;8:192–7.CrossRefPubMedGoogle Scholar
  30. 30.
    Werner JA, Dunne AA, Ramaswamy A, et al. The sentinel node concept in head and neck cancer: solution for controversies in the N0 neck? Head Neck. 2004;26:603–11.CrossRefPubMedGoogle Scholar
  31. 31.
    Werner JA, Dunne AA, Ramaswamy A, et al. Sentinel node detection in N0 cancer of the pharynx and larynx. Br J Cancer. 2002;87:711–5.CrossRefPubMedPubMedCentralGoogle Scholar
  32. 32.
    Werner JA, Dunne AA, Ramaswamy A, et al. Number and location of radiolabeled, intraoperatively identified sentinel nodes in 48 head and neck cancer patients with clinically staged N0 and N1 neck. Eur Arch Otorhinolaryngol. 2002;259:91–6.CrossRefPubMedGoogle Scholar
  33. 33.
    Civantos Jr F, Zitsch R, Bared A, et al. Sentinel node biopsy for squamous cell carcinoma of the head and neck. J Surg Oncol. 2008;97:683–90.CrossRefPubMedGoogle Scholar
  34. 34.
    Hart RD, Nasser JG, Trites JR, et al. Sentinel lymph node biopsy in N0 squamous cell carcinoma of the oral cavity and oropharynx. Arch Otolaryngol Head Neck Surg. 2005;131:34–8.CrossRefPubMedGoogle Scholar
  35. 35.
    Alkureishi LW, Ross GL, Shoaib T, et al. Sentinel node biopsy in head and neck squamous cell cancer: 5-year follow-up of a European multicenter trial. Ann Surg Oncol. 2010;17:2459–64.CrossRefPubMedGoogle Scholar
  36. 36.
    Sherman AI, Ter-Pogossian M. Lymph-node concentration of radioactive colloidal gold following interstitial injection. Cancer. 1953;6:1238–40.CrossRefPubMedGoogle Scholar
  37. 37.
    Strand SE, Persson BR. Quantitative lymphoscintigraphy I: basic concepts for optimal uptake of radiocolloids in the parasternal lymph nodes of rabbits. J Nucl Med. 1979;20:1038–46.PubMedGoogle Scholar
  38. 38.
    Sondak VK, King DW, Zager JS, Schneebaum S, Kim J, Leong SP, et al. Combined analysis of phase III trials evaluating [(9)(9)mTc]tilmanocept and vital blue dye for identification of sentinel lymph nodes in clinically node negative cutaneous melanoma. Ann Surg Oncol. 2013;20(2):680–8.CrossRefPubMedGoogle Scholar
  39. 39.
    Wallace AM, Han LK, Povoski SP, Deck K, Schneebaum S, Hall NC, et al. Comparative evaluation of [(99m)tc]tilmanocept for sentinel lymph node mapping in breast cancer patients: results of two phase 3 trials. Ann Surg Oncol. 2013;20(8):2590–9.CrossRefPubMedPubMedCentralGoogle Scholar
  40. 40.
    Marcinow AM, Hall N, Byrum E, Teknos TN, Old MO, Agrawal A. Use of a novel receptor-targeted (CD206) radiotracer, 99mTc-tilmanocept, and SPECT/CT for sentinel lymph node detection in oral cavity squamous cell carcinoma: initial institutional report in an ongoing phase 3 study. JAMA Otolaryngol Head Neck Surg. 2013;139(9):895–902.CrossRefPubMedPubMedCentralGoogle Scholar
  41. 41.
    Stoeckli SJ. Sentinel node biopsy for oral and oropharyngeal squamous cell carcinoma of the head and neck. Laryngoscope. 2007;117:1539–51.CrossRefPubMedGoogle Scholar
  42. 42.
    Terada A, Hasegawa Y, Goto M, et al. Sentinel lymph node radiolocalization in clinically negative neck oral cancer. Head Neck. 2006;28:114–20.CrossRefPubMedGoogle Scholar
  43. 43.
    Tschopp L, Nuyens M, Stauffer E, Krause T, Zbären P. The value of frozen section analysis of the sentinel lymph node in clinically N0 squamous cell carcinoma of the oral cavity and oropharynx. Otolaryngol Head Neck Surg. 2005;132:99–102.CrossRefPubMedGoogle Scholar
  44. 44.
    Trivedi NP, Ravindran HK, Sundram S, Iyer S, Kekatpure V, Durah S, Kuriakose MA. Pathologic evaluation of sentinel lymph nodes in oral squamous cell carcinoma. Head Neck. 2010;32(11):1437–43. doi: 10.1002/hed.21345.CrossRefPubMedGoogle Scholar
  45. 45.
    Asthana S, Deo SV, Shukla NK, Jain P, Anand M, Kumar R. Intraoperative neck staging using sentinel node biopsy and imprint cytology in oral cancer. Head Neck. 2003;25:368–72.CrossRefPubMedGoogle Scholar
  46. 46.
    Hamakawa H, Onishi A, Sumida T, et al. Intraoperative real-time genetic diagnosis for sentinel node navigation surgery. Int J Oral Maxillofac Surg. 2004;33:670–5.CrossRefPubMedGoogle Scholar
  47. 47.
    Devaney SL, Ferlito A, Rinaldo A, Devaney KO. The pathology of neck dissection in cancer of the larynx. ORL J Otorhinolaryngol Relat Spec. 2000;62:204–11.CrossRefPubMedGoogle Scholar
  48. 48.
    Shivers SC, Wang X, Li W, et al. Molecular staging of malignant melanoma: correlation with clinical outcome. JAMA. 1998;280:1410–5.CrossRefPubMedGoogle Scholar
  49. 49.
    Nelson BM. Sentinel lymph node biopsies in cancers of the skin, colon, head and neck, and breast. Proc (Bayl Univ Med Cent). 2004;17:99–103.Google Scholar
  50. 50.
    Stoeckli SJ, Pfaltz M, Ross GL, et al. The Second International Conference on sentinel node biopsy in mucosal head and neck cancer. Ann Surg Oncol. 2005;12:919–24.CrossRefPubMedGoogle Scholar
  51. 51.
    Xu X, Roberts SA, Pasha TL, Zhang PJ. Undesirable cytokeratin immunoreactivity of native nonepithelial cells in sentinel lymph nodes from patients with breast carcinoma. Arch Pathol Lab Med. 2000;124:1310–3.PubMedGoogle Scholar
  52. 52.
    Domagala W, Bedner E, Chosia M, et al. Keratin-positive reticulum cells in fine needle aspirates and touch imprints of hyperplastic lymph nodes. A possible pitfall in the immunocytochemical diagnosis of metastatic carcinoma. Acta Cytol. 1992;36:241–5.PubMedGoogle Scholar
  53. 53.
    Hermanek P, Hutter RV, Sobin LH, Wittekind C. International Union Against Cancer. Classification of isolated tumor cells and micrometastasis. Cancer. 1999;86:2668–73.CrossRefPubMedGoogle Scholar
  54. 54.
    American Joint Committee on Cancer. Cancer staging manual. 6th ed. New York: Springer; 2002. p. 223–40.CrossRefGoogle Scholar
  55. 55.
    Ferlito A, Partridge M, Brennan J, Hamakawa H. Lymph node micrometastases in head and neck cancer: a review. Acta Otolaryngol. 2001;121:660–5.CrossRefPubMedGoogle Scholar
  56. 56.
    Devaney KO, Rinaldo A, Ferlito A. Micrometastasis in cervical lymph nodes from patients with squamous carcinoma of the head and neck: should they be actively sought? Maybe. Am J Otolaryngol. 2007;28:271–4.CrossRefPubMedGoogle Scholar
  57. 57.
    Stoeckli SJ, Pfaltz M, Steinert H, Schmid S. Histopathological features of occult metastasis detected by sentinel lymph node biopsy in oral and oropharyngeal squamous cell carcinoma. Laryngoscope. 2002;112:111–5.CrossRefPubMedGoogle Scholar
  58. 58.
    Schiefke F, Akdemir M, Weber A, Akdemir D, Singer S, Frerich B. Function, postoperative morbidity, and quality of life after cervical sentinel node biopsy and after selective neck dissection. Head Neck. 2009;31(4):503–12.CrossRefPubMedGoogle Scholar
  59. 59.
    Murer K, Huber GF, Haile SR, Stoeckli SJ. Comparison of morbidity between sentinel node biopsy and elective neck dissection for treatment of the n0 neck in patients with oral squamous cell carcinoma. Head Neck. 2011;33(9):1260–4.CrossRefPubMedGoogle Scholar
  60. 60.
    Hernando J, Villarreal P, Alvarez-Marcos F, Gallego L, García-Consuegra L, Junquera L. Comparison of related complications: sentinel node biopsy versus elective neck dissection. Int J Oral Maxillofac Surg. 2014. pii: S0901-5027(14)00266-5. doi: 10.1016/j.ijom.2014.07.016.
  61. 61.
    Paleri V, Rees G, Arullendran P, et al. Sentinel node biopsy in squamous cell carcinoma of the oral cavity: a diagnostic meta-analysis. Head Neck. 2005;27:739–47.CrossRefPubMedGoogle Scholar
  62. 62.
    Govers TM, Hannink G, Merkx MA, Takes RP, Rovers MM. Sentinel node biopsy for squamous cell carcinoma of the oral cavity and oropharynx: a diagnostic meta-analysis. Oral Oncol. 2013;49(8):726–32. doi: 10.1016/j.oraloncology.2013.04.006.CrossRefPubMedGoogle Scholar
  63. 63.
    Alvarez J, Bidaguren A, McGurk M, Diaz-Basterra G, Brunso J, Andikoetxea B, et al. Sentinel node biopsy in relation to survival in floor of the mouth carcinoma. Int J Oral Maxillofac Surg. 2014;43:269–73.CrossRefPubMedGoogle Scholar
  64. 64.
    Barzan L, Sulfaro S, Alberti F, Politi D, Marus W, Pin M, et al. Gamma probe accuracy in detecting the sentinel lymph node in clinically N0 squamous cell carcinoma of the head and neck. Ann Otol Rhinol Laryngol. 2002;111(9):794–8.CrossRefPubMedGoogle Scholar
  65. 65.
    Bilde A, von Buchwald C, Therkildsen MH, Mortensen J, Kirkegaard J, Charabi B, et al. Need for intensive histopathologic analysis to determine lymph node metastases when using sentinel node biopsy in oral cancer. Laryngoscope. 2008;118(3):408–14.CrossRefPubMedGoogle Scholar
  66. 66.
    Burcia V, Costes V, Faillie JL, Gardiner Q, de Verbizier D, Cartier C, et al. Neck restaging with sentinel node biopsy in T1-T2N0 oral and oropharyngeal cancer: why and how? Otolaryngol Head Neck Surg Off J Am Acad Otolaryngol Head Neck Surg. 2010;142(4):592–7. e591.CrossRefGoogle Scholar
  67. 67.
    Chikamatsu K, Kamada H, Ninomiya H, Takahashi K, Sakurai T, Oriuchi N, et al. A preliminary study on sentinel lymph node biopsy: feasibility and predictive ability in oral cavity cancer. Ann Nucl Med. 2004;18(3):257–62.CrossRefPubMedGoogle Scholar
  68. 68.
    Civantos FJ, Gomez C, Duque C, Pedroso F, Goodwin WJ, Weed DT, et al. Sentinel node biopsy in oral cavity cancer: correlation with PET scan and immunohistochemistry. Head Neck. 2003;25(1):1–9.CrossRefPubMedGoogle Scholar
  69. 69.
    Dequanter D, Shahla M, Paulus P, Lothaire P. Long term results of sentinel lymph node biopsy in early oral squamous cell carcinoma. Oncotargets Ther. 2013;6:799–802.CrossRefGoogle Scholar
  70. 70.
    Fan SF, Zeng ZY, Peng HW, Guo ZM, Wang SL, Zhang Q. Sentinel lymph node biopsy versus elective neck dissection in patients with cT1-2N0 oral tongue squamous cell carcinoma. Oral Surg Oral Med Oral Pathol Oral Radiol. 2014;117(2):186–90.CrossRefPubMedGoogle Scholar
  71. 71.
    Kontio R, Leivo I, Leppanen E, Atula T. Sentinel lymph node biopsy in oral cavity squamous cell carcinoma without clinically evident metastasis. Head Neck. 2004;26(1):16–21.CrossRefPubMedGoogle Scholar
  72. 72.
    Pezier T, Nixon IJ, Gurney B, Schilling C, Hussain K, Lyons AJ, et al. Sentinel lymph node biopsy for T1/T2 oral cavity squamous cell carcinoma–a prospective case series. Ann Surg Oncol. 2012;19(11):3528–33.CrossRefPubMedGoogle Scholar
  73. 73.
    Rigual N, Loree T, Frustino J, Jayaprakash V, Cohan D, Sullivan M, et al. Sentinel node biopsy in lieu of neck dissection for staging oral cancer. JAMA Otolaryngol Head Neck Surg. 2013;139(8):779–82.CrossRefPubMedGoogle Scholar
  74. 74.
    Sebbesen L, Bilde A, Therkildsen M, Mortensen J, Spect L, von Buchwald C. Three-year follow-up of sentinel node-negative patients with early oral cavity squamous cell carcinoma. Head Neck. 2014;36:1109–12.CrossRefPubMedGoogle Scholar
  75. 75.
    Taylor RJ, Wahl RL, Sharma PK, Bradford CR, Terrell JE, Teknos TN, et al. Sentinel node localization in oral cavity and oropharynx squamous cell cancer. Arch Otolaryngol Head Neck Surg. 2001;127(8):970–4.CrossRefPubMedGoogle Scholar
  76. 76.
    Zitsch RP, Todd DW, Renner GJ, Singh A. Intraoperative radiolymphoscintigraphy for detection of occult nodal metastasis in patients with head and neck squamous cell carcinoma. Otolaryngol Head Neck Surg Off J Am Acad Otolaryngol Head Neck Surg. 2000;122(5):662–6.CrossRefGoogle Scholar
  77. 77.
    Civantos FJ, Zitsch RP, Schuller DE, Agrawal A, Smith RB, Nason R, et al. Sentinel lymph node biopsy accurately stages the regional lymph nodes for T1-T2 oral squamous cell carcinomas: results of a prospective multi-institutional trial. J Clin Oncol Off J Am Soc Clin Oncol. 2010;28(8):1395–400.CrossRefGoogle Scholar
  78. 78.
    Thompson CF, St John MA, Lawson G, Grogan T, Elashoff D, Mendelsohn AH. Diagnostic value of sentinel lymph node biopsy in head and neck cancer: a meta-analysis. Eur Arch Otorhinolaryngol Off J Eur Fed Otorhinolaryngological Soc. 2013;270(7):2115–22.CrossRefGoogle Scholar
  79. 79.
    Broglie MA, Haile SR, Stoeckli SJ. Long-term experience in sentinel node biopsy for early oral and oropharyngeal squamous cell carcinoma. Ann Surg Oncol. 2011;18:2732–8.CrossRefPubMedGoogle Scholar
  80. 80.
    Flach GB, Bloemena E, Klop WM, van Es RJ, Schepman KP, Hoekstra OS, Castelijns JA, Leemans CR, de Bree R. Sentinel lymph node biopsy in clinically N0 T1-T2 staged oral cancer: the Dutch multicenter trial. Oral Oncol. 2014;50(10):1020–4. doi: 10.1016/j.oraloncology.2014.07.020.CrossRefPubMedGoogle Scholar
  81. 81.
    Civantos FJ, Moffat FI, Goodwin WJ. Lymphatic mapping and sentinel lymphadenectomy for 106 head and neck lesions: contrasts between oral cavity and cutaneous malignancy. Laryngoscope. 2006;16:1–15.CrossRefGoogle Scholar
  82. 82.
    Kuriakose MA, Trivedi NP. Sentinel node biopsy in head and neck squamous cell carcinoma. Curr Opin Otolaryngol Head Neck Surg. 2009;17(2):100–10. doi: 10.1097/MOO.0b013e3283293631.CrossRefPubMedGoogle Scholar
  83. 83.
    Nason RW, Torchia MG, Morales CM, Thliveris J. Dynamic MR lymphangiography and carbon dye for sentinel node detection: a solution for sentinel lymph node biopsy in mucosal head and neck cancer. Head Neck. 2005;27:333–8.CrossRefPubMedGoogle Scholar
  84. 84.
    Klutmann S, Bohuslavizki KH, Brenner W, et al. Lymphoscintigraphy in tumors of the head and neck using double tracer technique. J Nucl Med. 1999;40:776–82.PubMedGoogle Scholar
  85. 85.
    Woolgar JA. Micrometastasis in oral/oropharyngeal squamous cell carcinoma: incidence, histopathological features and clinical implications. Br J Oral Maxillofac Surg. 1999;37:181–6.CrossRefPubMedGoogle Scholar
  86. 86.
    Yamazaki Y, Chiba I, Hirai A, et al. Clinical value of genetically diagnosed lymph node micrometastases for patients with oral squamous cell carcinoma. Head Neck. 2005;27:676–81.CrossRefPubMedGoogle Scholar
  87. 87.
    Colnot DR, Nieuwenhuis EJC, Kuik DJ, et al. Clinical significance of micrometastatic cells detected by E48 (Ly-6D) reverse transcriptase: polymerase chain reaction in bone marrow of head and neck cancer patients. Clin Cancer Res. 2004;10:7827–33.CrossRefPubMedGoogle Scholar
  88. 88.
    Morton DL. Lymphatic mapping and sentinel lymphadenectomy for melanoma: past, present and future. Ann Surg Oncol. 2001;8(9 Suppl):22S–8.PubMedGoogle Scholar
  89. 89.
    Heuveling DA, van Schie A, Vugts DJ, et al. Pilot study on the feasibility of PET/CT lymphoscintigraphy with 89Zr-nanocolloidal albumin for sentinel node identification in oral cancer patients. J Nucl Med. 2013;54:585–9.CrossRefPubMedGoogle Scholar
  90. 90.
    Vermeeren L, Valdés Olmos RA, Klop WM, Balm AJ, van den Brekel MW. A portable gamma-camera for intraoperative detection of sentinel nodes in the head and neck region. J Nucl Med. 2010;51:700–3.CrossRefPubMedGoogle Scholar
  91. 91.
    Heuveling DA, Karagozoglu KH, van Schie A, van Weert S, van Lingen A, de Bree R. Sentinel node biopsy using 3D lymphatic mapping by freehand SPECT in early stage oral cancer: a new technique. Clin Otolaryngol. 2012;371:89–90.CrossRefGoogle Scholar
  92. 92.
    van den Berg NS, Brouwer OR, Klop WM, Karakullukcu B, Zuur CL, Tan IB, Balm AJ, van den Brekel MW, Valdés Olmos RA, van Leeuwen FW. Concomitant radio- and fluorescence-guided sentinel lymph node biopsy in squamous cell carcinoma of the oral cavity using ICG-(99m)Tc-nanocolloid. Eur J Nucl Med Mol Imaging. 2012;39(7):1128–36. doi: 10.1007/s00259-012-2129-5.CrossRefPubMedGoogle Scholar
  93. 93.
    Heuveling DA, Visser GW, de Groot M, et al. Nanocolloidal albumin- IRDye 800CW: a near-infrared fluorescent tracer with optimal retention in the sentinel lymph node. Eur J Nucl Med Mol Imaging. 2012;39:1161–8.CrossRefPubMedPubMedCentralGoogle Scholar

Copyright information

© Springer International Publishing Switzerland 2017

Authors and Affiliations

  • Krishnakumar Thankappan
    • 1
  • Moni Abraham Kuriakose
    • 2
    Email author
  1. 1.Department of Head and Neck Surgery and OncologyAmrita Institute of Medical Sciences, Amrita UniversityKochiIndia
  2. 2.Department of Head and Neck, Plastic and Reconstructive Surgery, Dental and Maxillofacial ProsthodonticsRoswell Park Cancer InstituteBuffaloUSA

Personalised recommendations